Professor of Clinical Oncology
On this web site you will find information about my scientific work within cancer research,
as well as other activities.
My clinical experience and research are mainly devoted to primary bone and soft tissue cancers (sarcomas) and skeletal metastases from prostate cancer and breast cancer. In particular, targeted radionuclide therapy, e.g. Alpharadin (Algeta), based on Radium-223, is currently at center stage.
|Seksjonsoverlege Øyvind Bruland
Det Norske Radiumhospital
|Professor of Clinical Oncology
Department of Medical Oncology & Radiotherapy
The Norwegian Radium Hospital
N-0310 Oslo, NORWAY
Tel. + 47 22 93 40 00
Dir. + 47 22 93 47 67
Fax. + 47 22 52 55 59
This handbook of 2010 compiles a clear summary of clinically relevant information with recommendations for treatment of cancer-related bone disease. By activating the hyperlink below, you may find information on the book with its contents and preface, contributors and a pdf of a chapter on "Radio-isotope treatments for bone metastases".
Handbook of Cancer-Related Bone Disease (PDF) (2nd edtition)
The book is available to order from the distributor's website: click here
In essence the scope and intensive coverage of the book provides a historical perspective of the advances made over the past 30 years and emerging concepts and prospects for new diagnostic and therapeutic approaches. This is based upon past experiences and new discoveries. It also provides a unique opportunity for pediatric and adult medical oncologists, physicians in training, orthopedic surgeons, pathologists, radiologists, radiotherapists, oncology nurses and allied professionals involved in the care of pediatric/adolescent patients with osteosarcoma to become acquainted with prevailing methods of treatment and new and evolving concepts and developments.
Click here to view a flyer on the book (Word format)
Click here to view table of contents
A link to this book from Springer Verlag: click here
An interview with professor Øyvind S. Bruland has recently been published on the University of Oslo web page, in their popular scientific series "Interviews with researchers" (in Norwegian). It is entitled "Raketter og tverrfaglighet i kampen mot kreft" ("Rockets and interdisciplinarity in the fight against cancer").
Øyvind S. Bruland's research is mainly devoted to primary bone and soft tissue cancers (sarcomas) and skeletal metastases from prostate cancer and breast cancer.
A comprehensive review on the use of bone-seeking radiopharmaceuticals; including Alpharadin, in bone-metastatic patients was publisehed in Cancer Treatment Reviews, 2012. Click here for a pdf of the publication
Some key issues to understand this promising new treatment strategy
Click here to view the presentation (PDF format)
In the latest issue of Clinical Cancer Research, a separate section is devoted to the proceedings from an expert meeting in Boston, October last year. Here invited papers on various aspects of the management of patients with bone metastases are published. This includes a review (by Bruland et al.) on external radiotherapy, bone-seeking radiopharamaceuticals, including recent progress using Alpharadin - a novel bone-seeker; currently in phase II clinical testing in patients with bone metastases from hormone refractory prostate cancer.
Click here to view the table of contents (PDF format)
High-Linear EnergyTransfer IrradiationTargeted to Skeletal Metastases by the A-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities? (PDF format)
Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference (PDF format)
|Skeletal metastases and radiotherapy (19.11.2008 14:23)|